# Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause

> **NCT00290212** · PHASE2 · COMPLETED · sponsor: **University Hospital of North Norway** · enrollment: 304 (actual)

## Conditions studied

- Perimenopausal Bone Loss

## Interventions

- **DRUG:** Natto capsules (food suppl.) cont. 360 microg. vit K2/day
- **DRUG:** Placebo capsules

## Key facts

- **NCT ID:** NCT00290212
- **Lead sponsor:** University Hospital of North Norway
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 304 (ACTUAL)
- **Last updated:** 2008-01-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00290212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00290212, "Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00290212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*